We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-11.81%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73M
AUM Growth
-$5.17B
Cap. Flow
-$776M
Cap. Flow %
-13,535.32%
Top 10 Hldgs %
49.82%
Holding
217
New
75
Increased
44
Reduced
24
Closed
41

Top Buys

Rank Stock Value
1
ORLY icon
O'Reilly Automotive
ORLY
+$93.9M
2
LULU icon
lululemon athletica
LULU
+$73.2M
3
DG icon
Dollar General
DG
+$71.9M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$67.6M
5
NBIX icon
Neurocrine Biosciences
NBIX
+$62.2M

Top Sells

Rank Stock Value
1
HD icon
Home Depot
HD
+$105M
2
BIIB icon
Biogen
BIIB
+$68.7M
3
TGT icon
Target
TGT
+$68.3M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$62.1M
5
OCDX
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
+$62M

Sector Composition

Rank Sector Weight
1 Healthcare 44.4%
2 Consumer Staples 8.91%
3 Consumer Discretionary 7.35%
4 Technology 4.07%
5 Communication Services 1.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNAX
126
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$1.07K 0.02%
81,136
+37,557
+86% +$612K
BCTXW
127
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$975 0.02%
375,000
– –
CELZ icon
128
Creative Medical Technology
CELZ
$4.24M
$933 0.02%
+124,418
New +$2.01M
OG
129
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$830 0.01%
943,390
– –
TERN
130
DELISTED
Terns Pharmaceuticals
TERN
$801 0.01%
+323,016
New +$645K
EFOI icon
131
Energy Focus
EFOI
$19.4M
$796 0.01%
+87,473
New +$807K
REAL icon
132
The RealReal
REAL
$1.51B
$747 0.01%
+300,000
New +$1.34M
NCEL
133
NewcelX Ltd
NCEL
$18.4M
$714 0.01%
+3,041
New +$951K
SPRC icon
134
SciSparc
SPRC
$4.1M
$714 0.01%
+68
New +$935K
TOPS icon
135
TOP Ships
TOPS
$4.07M
$695 0.01%
+7,637
New +$1.25M
SBEV.WS
136
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$651 0.01%
904,000
– –
TENX icon
137
Tenax Therapeutics
TENX
$536M
$479 0.01%
998
-264
-21% -$264K
INM icon
138
InMed Pharmaceuticals
INM
$7.8M
$450 0.01%
+1,912
New +$731K
DRMA icon
139
Dermata Therapeutics
DRMA
$4.32M
$414 0.01%
+265
New +$546K
MTEKW icon
140
Maris-Tech Ltd Warrants
MTEKW
$959K
$411 0.01%
1,261,058
– –
TCBPW
141
DELISTED
TC BioPharm (Holdings) plc Warrants
TCBPW
$381 0.01%
1,882,352
– –
FGIWW
142
FGI Industries Warrant
FGIWW
$180K
$369 0.01%
933,333
– –
DRCTW
143
DELISTED
Direct Digital Holdings, Inc. Warrant
DRCTW
$351 0.01%
900,000
– –
SKYAW
144
SkyAI Inc
SKYAW
$263K
$327 0.01%
+1,176,000
New +$486K
GMBLZ
145
DELISTED
Esports Entertainment Group Inc. Warrant
GMBLZ
$324 0.01%
2,700,000
– –
EDBLW
146
Edible Garden AG Warrant
EDBLW
$128K
$320 0.01%
+800,000
New +$329K
MDGSW
147
DELISTED
Medigus Ltd. Series C Warrant
MDGSW
$318 0.01%
1,285,715
– –
BNBX
148
DELISTED
BNB PLUS CORP
BNBX
$295 0.01%
27
-4
-13% -$84.7K
ADXN
149
Addex Therapeutics
ADXN
$291 0.01%
12,651
-15,753
-55% -$1.18M
RMTI icon
150
Rockwell Medical
RMTI
$28.5M
$266 ﹤0.01%
+20,651
New +$546K
4 5
6
7 8

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Armistice Capital held 217 positions worth $5.73M, down 100% from $5.17B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Armistice Capital withdrew a net $776M in Q2 2022, closing 41 positions and reducing 24 holdings. Its most notable exit was Home Depot, an estimated $105M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Armistice Capital opened a new position in O'Reilly Automotive worth $92K.

  • Armistice Capital's largest Q2 2022 buy was O'Reilly Automotive: 2,183,715 shares worth $92K.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2022, an estimated $67.6M increase.
  • Armistice Capital's biggest Q2 2022 reduction was Biogen, cutting an estimated $68.7M.
  • Armistice Capital fully exited Home Depot in Q2 2022, selling an estimated $105M.
  • Armistice Capital's ten largest holdings make up 50% of its $5.73M portfolio in Q2 2022.
  • Armistice Capital opened 75 new positions and closed 41 in Q2 2022.
  • Armistice Capital's portfolio value fell 100% quarter-over-quarter to $5.73M.

Based on Armistice Capital's 13F filing for Q2 2022, filed 15 Aug 2022.